Market Synopsis
Fibroadenomas are benign breast tumors characterized by a mixture of epithelial and stromal tissue. As per a new detailed report by Market Research Future (MRFR), the global market for fibroadenoma is projected to exhibit a 4.9 % CAGR during the forecasted period (2017-2023). and It is expected to reach $USD 800 million. Caused due to hormone imbalances, the symptoms of fibroadenoma are firm and , painless, mobile lump in a woman’s breast.. The growth of these tumors is generally faster during pregnancy, but during menopause, they tend to shrink. Removal of fibroadenomas is always recommended, but these tumors shrink or even stop growing on their own. They are also termed known as breast mice due to the high mobility. These tumors generally occur among women in theirin the age of 20s and 30s. It is said that aAvoiding drinks and foods that which act as stimulants such as chocolate, tea, coffee and soft drinks can improve breast symptoms.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/3997
Although non-invasive diagnosis like ultrasound is in demand, a biopsy is the best way to detect fibroadenomas. Also, Surgeries like such as cryoablation, which uses ultrasound to destroy eliminate tumors fibroadenoma are also in high demand. The non-invasive nature of these treatments can helps to in reduce reducing trauma and pain levels associated with these surgeries.
Drivers and Restraints
With the growing acceptance of surgery worldwide and rising per capita income, the market is sure to grow in future. Also, the Adoption of latest technologies and devices is can also driving drive the market. Imaging devices which can detect the size of these tumors can bode well for the market. Meanwhile, the self-resolving and non-life threatening nature of fibroadenoma are the key restraints of this market.
Global Fibroadenoma Market Segmentation
The global fibroadenoma market can be segmented on the basis of diagnosis, type, end users, and treatment
On the basis of type, the market can be segmented into simple and complex fibroadenoma. The simple tumors are harmless and do not increase the cancer risk. The complex tumors contain components such as macrocysts which are large enough to see and feel without the help of a microscope. These complex tumors also contain calcium deposits referred to as calcifications. Complex fibroadenomas increase the risk of breast cancer to a large extent.
Based on diagnosis, the market has been segmented into biopsy, physical examination, ultrasound scan, mammogram, and others.
On the basis of treatment, The the market can be segmented into drugs, High high Intensity intensity Focused focused Ultrasound ultrasound (HIFU), cryoablation, surgery, and others on the basis of treatment.
Based on end-users, the market can be segmented into diagnostic centers, hospitals and clinics, and others.
Regional Analysis
Regions covered in the fibroadenoma market are North America, Europe, Asia Pacific, and Middle East and Africa (MEA). In the North America market, The the United States is considered to hold the maximum market share because ofowing to attractive insurance penetration which results in reimbursement scenarioschemes and higher budgetary expenditure on for the healthcare sector. Adoption of new devices and technology technologies in the U.S. is also an important factor for catapulting the North America market growth in this regionto the topmost position.
Europe holds the second position in the market due to rising awareness and high disposable incomes of patients. Innovations in this region are also expected to drive market growth during the forecast period. For instance, Theraclion, aa Paris, Franceench firm, devised EchoPulse focused ultrasound system for treating fibroadenomas and won the European CE Mark approval. This device uses ultrasound thatto detects and attack tumors in real time without the need for general anesthesia. Asia Pacific is expected to grow at a fast rapid growth rate in years to comethe coming years. and isIt is estimated likely to be led by China and India.
The Middle East and AfricaEA market are is expected to witness a moderate growth because ofowing to poor political and economic conditions and poor healthcare penetration.
Browse Complete Report with TOC at
https://www.marketresearchfuture.com/reports/fibroadenoma-market-3997
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
No comments:
Post a Comment